NCT00200538View on ClinicalTrials.gov

Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients

PHASE2CompletedINTERVENTIONAL

Enrollment

52

Participants

Timeline

Start Date

September 30, 2005

Conditions

Dementia

Interventions

DRUG

memantine

Trial Locations (1)

44093

Martine Vercelletto, Nantes

All Listed Sponsors

lead

Nantes University Hospital

OTHER

NCT00200538 - Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients | Biotech Hunter | Biotech Hunter